Research Ethics and Integrity

12. 4. 2023, Masaryk University, Brno

Any human activity provides room for immoral or even fraudulent behavior, and basic research is no exception. The workshop, organized in cooperation with Masaryk University in Brno, will provide listeners with an overview of dubious actions that a scientist may commit and offer a modern perspective on how to improve the situation in several of such areas.


The workshop is open to scientists in any research field and of any academic age as well as for representatives of research administration. The workshop language is English.

This workshop is co-organized with Masaryk University with the support of the Alexander von Humboldt Foundation.

Registration to the seminar is closed.


14:00 - 14:10

Opening word

14:10 - 15:30

Invited talks

15:30 - 15:50


15:50 - 16:30

Panel discussion

16:30- 17:30

Refreshments, networking, informal discussion


Mgr. Michaela Dohnálková

University of Geneva, Switzerland

mRNA molecules consist of four nucleotides AUCG that can be further modified to attract the cellular machineries deciding the fate of mRNA. The research of Michaela focuses on modifications on the very beginning of mRNAs - mRNA cap structure and its involvement in the innate immunity, development and molecular functions. She obtained her bachelor's and master's degrees from Masaryk University Brno, Czech Republic. During her undergraduate years she worked at CEITEC MUNI. Then, she moved to Switzerland where she is finishing her PhD studies in molecular biology at the University of Geneva. Michaela enjoys playing board games, bouldering, hiking and observing animals. Recently, she found a passion in linocut.

prof. MUDr. Jan Trka, Ph.D.

Second Faculty of Medicine, Charles University, Prague, Czechia

Jan Trka is a paediatric haematologist, since the 1990s he has been involved in genetic and genomic diagnostics of childhood leukaemias and research on the origin and development of leukaemic clone. He co-founded the scientific group CLIP (Childhood Leukaemia Investigation Prague) and trained several top scientists.
Recently he has been more involved in the management of this research group and unfortunately mostly in administrative duties at the 2nd Faculty of Medicine, Charles University and Motol Hospital.

Mgr. Pavel Tomančák, Ph.D.

Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany
Central European Institute of Science and Technology, Brno, Czechia 

Pavel Tomančák is an evolutionary developmental biologist who has led an independent research group at the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden since 2005. His laboratory is dedicated to studying the evolution of morphogenesis during the embryonic development of multicellular organisms. His research is unique due to the combination of advanced molecular analysis methods with state-of-the-art imaging and computational analysis of microscopic data.

He started his scientific career at Masaryk University, studying molecular biology and genetics. He completed doctoral studies at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. He then worked for five years at the University of California, Berkeley, in the group of the American geneticist Gerald M. Rubin. He has received two grants of the European Research Council and has been a member of EMBO since 2016. 

From 1 February 2021, he became the Director of the CEITEC consortium in Brno, where he leverages his international experience to boost CEITEC’s ambition to become a significant player in the field of science, at least in Europe.